Literature DB >> 22411243

Machado-Joseph disease and other rare spinocerebellar ataxias.

Antoni Matilla-Dueñas1.   

Abstract

The spinocerebellar ataxias (SCAs) are a group of neurodegenerative diseases characterised by progressive lack of motor coordination leading to major disability. SCAs show high clinical, genetic, molecular and epidemiological variability. In the last one decade, the intensive scientific research devoted to the SCAs is resulting in clear advances and a better understanding on the genetic and nongenetic factors contributing to their pathogenesis which are facilitating the diagnosis, prognosis and development of new therapies. The scope of this chapter is to provide an updated information on Machado-Joseph disease (MJD), the most frequent SCA subtype worldwide and other rare spinocerebellar ataxias including dentatorubral-pallidoluysian atrophy (DRPLA), the X-linked fragile X tremor and ataxia syndrome (FXTAS) and the nonprogressive episodic forms of inherited ataxias (EAs). Furthermore, the different therapeutic strategies that are currently being investigated to treat the ataxia and non-ataxia symptoms in SCAs are also described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411243     DOI: 10.1007/978-1-4614-0653-2_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  The ever expanding spinocerebellar ataxias. Editorial.

Authors:  Antoni Matilla-Dueñas
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

Review 2.  Deafness and Vestibulopathy in Cerebellar Diseases: a Practical Approach.

Authors:  Orlando G Barsottini; José Luiz Pedroso; Carlos Roberto Martins; Marcondes Cavalcante França; Pedro Mangabeira Albernaz
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

Review 3.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

4.  Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3.

Authors:  Carmen Rodríguez-Cueto; Mariluz Hernández-Gálvez; Cecilia J Hillard; Patricia Maciel; Sara Valdeolivas; José A Ramos; María Gómez-Ruiz; Javier Fernández-Ruiz
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

Review 5.  Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.

Authors:  María Gómez-Ruiz; Carmen Rodríguez-Cueto; Eva Luna-Piñel; Mariluz Hernández-Gálvez; Javier Fernández-Ruiz
Journal:  Front Mol Neurosci       Date:  2019-04-24       Impact factor: 5.639

6.  Assessment of Bone Mineral Density of Patients with Spinocerebellar Ataxia Type 3.

Authors:  Aline Ms Farias; Simone Appenzeller; Marcondes C França; Alberto Rm Martinez; Elba E Etchebehere; Thiago F Souza; Allan O Santos
Journal:  J Mov Disord       Date:  2019-01-30

7.  Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model.

Authors:  Francesca Maltecca; Elisa Baseggio; Francesco Consolato; Davide Mazza; Paola Podini; Samuel M Young; Ilaria Drago; Ben A Bahr; Aldamaria Puliti; Franca Codazzi; Angelo Quattrini; Giorgio Casari
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.